<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14992</id><no>A021901-NCT04665739</no><status>Open</status><title>Randomized Phase II Trial of Lutetium Lu 177 Dotatate Versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors </title><secondary_protocol_no>A021901</secondary_protocol_no><nct_id>NCT04665739</nct_id><sponsor_type>National</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><scope>National</scope><disease_site>Other</disease_site><PI>Kim, Chul</PI><institution>Georgetown University Medical Center : Alan Zwart; Lombardi Comprehensive Cancer Center : Alan Zwart</institution><oncology_group>Thoracic/CNS/H&amp;N/Thyroid<DOWG_name>Oncology Group</DOWG_name></oncology_group><management_group>Lombardi Comprehensive Cancer Center (LCCC)</management_group><item><contact_id>16795</contact_id><item_description>Alan Zwart</item_description><js_safe_str>Alan Zwart</js_safe_str><email>az6@georgetown.edu</email></item></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>